Quinidine Gluconate Tablet, Extended Release
NDC Package 51407-288-01

11-digit billing NDC: 51407028801 · Billing unit: EA · 100 EA per package

Package Information

Quinidine Gluconate tablets is quinidine is contraindicated in patients who are known to be allergic to it, or who have a history of immune thrombocytopenia or have developed thrombocytopenic purpura during prior therapy with quinidine or quinine (see WARNINGS). This formulation utilizes a tablet, extended release delivery system. Marketed by Golden State Medical Supply, this product is identified by NDC 51407-288 and is authorized under FDA application ANDA089338.

Identification & Billing

NDC Package Code
51407-288-01
Package Description
100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
51407028801
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 852920 - quiNIDine gluconate 324 MG Extended Release Oral Tablet
  • RxCUI: 852920 - quinidine gluconate 324 MG Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Quinidine Gluconate
Non-Proprietary Name
Quinidine Gluconate
Substance Name
Quinidine Gluconate
Dosage Form
Tablet, Extended Release - A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Quinidine is contraindicated in patients who are known to be allergic to it, or who have a history of immune thrombocytopenia or have developed thrombocytopenic purpura during prior therapy with quinidine or quinine (see WARNINGS). In the absence of a functioning artificial pacemaker, quinidine is also contraindicated in any patient whose cardiac rhythm is dependent upon a junctional or idioventricular pacemaker, including patients in complete atrioventricular block.Quinidine is also contraindicated in patients who, like those with myasthenia gravis, might be adversely affected by an anticholinergic agent.

Regulatory & Marketing

Labeler Name
Golden State Medical Supply
Product Type
Human Prescription Drug
FDA Application #
ANDA089338
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-11-1987
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51407-288-01 identifies a specific commercial package of 100 tablet, extended release in 1 bottle, plastic of Quinidine Gluconate, a human prescription drug labeled by Golden State Medical Supply. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet, extended release is formulated for oral use and contains quinidine gluconate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Golden State Medical Supply on February 11, 1987. The current certification is valid through December 31, 2026.

How is this Golden State Medical Supply product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51407028801. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51407-288-01
11-Digit CMS (5-4-2)
51407-0288-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.